Related Experiment Video

Updated: Apr 10, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

15.7K

The Associations between RNA Splicing Complex Gene SF3A1 Polymorphisms and Colorectal Cancer Risk in a Chinese

Xiaohua Chen1, Hua Du2, Binjian Liu2

  • 1Department of Medical Genetics, School of Basic Medical Science, Wuhan University, Wuhan, 430071, China; Department of Laboratory Medicine, No 161 Hospital of PLA, Wuhan, 430010, China.

Plos One
|June 17, 2015
PubMed
Abstract

Insights

This study found no association between SF3A1 gene polymorphisms and colorectal cancer (CRC) risk in a Chinese population. Further research is needed to confirm these findings on CRC development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Aberrant alternative splicing is common in colon cancer.
  • SF3A1, a key splicing factor, has an unclear role in colorectal cancer (CRC) risk.
  • Understanding SF3A1's role is crucial for CRC research.

Purpose of the Study:

  • To investigate the association between SF3A1 gene polymorphisms and CRC risk.
  • To analyze specific single nucleotide polymorphisms (SNPs) in the SF3A1 gene.
  • To evaluate the influence of SF3A1 variations on CRC susceptibility in a Chinese population.

Main Methods:

  • A hospital-based case-control study was conducted.
  • 801 CRC patients and 817 cancer-free controls were included.
  • Four candidate SF3A1 SNPs (rs10376, rs5753073, rs2839998, rs2074733) were analyzed.

Main Results:

  • No significant association was found between the studied SF3A1 SNPs and CRC risk (P > 0.05).
  • Stratified analyses based on smoking and alcohol consumption also yielded no significant results.
  • The investigated genetic variations in SF3A1 do not appear to influence CRC risk in this population.

Conclusions:

  • This is the first study to examine SF3A1 polymorphisms in relation to CRC risk.
  • The findings suggest that the four selected SF3A1 SNPs are not associated with CRC risk in the studied Chinese population.
  • Further studies are warranted to validate these results and explore other potential genetic factors in CRC development.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.7K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.8K
RNA Splicing01:32

RNA Splicing

20.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.8K